Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/nrAohMrCCBwWABFSyf

December 11, 2008News for medical technology professionals

  Top Story 
 
Combined ExpertiseSuperior Protection
When an officer of an early stage technology company became embroiled in a wrongful employment practices charge, the allegation created a distraction from the company's implementation schedule. Click here to read how this situation illustrates the value of having a strong insurer as a risk management partner.
www.medmarc.com                      www.thehartford.com
  Business & Market Trends 
  • Healionics gets $2.6M in funding
    Healionics has secured $2.6 million from Bellingham Angel Group and other private investors that participated in a second round of funding. The company plans to use the money to conduct further studies on the efficacy of its product, a biocompatible material used in medical implants. The Seattle Times (12/11) LinkedInFacebookTwitterEmail this Story
  Science & Health 
  • Study: Brain MRIs could help in early detection of multiple sclerosis
    A U.S. study found that 30% of individuals whose brain MRIs revealed abnormalities similar to those found in multiple sclerosis patients went on to develop the condition within 5.4 years. The finding suggests that brain scans using MRI could help in spotting the disease long before MS symptoms show, researchers said. Yahoo!/Reuters (12/10) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 
  • Access Scientific gets FDA approval for MicroAccess WAND
    The FDA has approved Access Scientific's MicroAccess WAND, a safety introducer that allows doctors to put a catheter or a sheath into the peripheral vasculature during procedures. The clearance enables the clinical facilities to immediately use the device, said the company's CEO, Dr. Steve Bierman. HealthImaging.com (12/10) LinkedInFacebookTwitterEmail this Story
  • FDA approves 3-D cardiac application from Viatronix
    The FDA has given 510(k) clearance to Viatronix for its V3D-Cardiac module, which offers left-ventricle and coronary-analysis functions in a single application. The product can also be incorporated into PACS workstations and can evaluate cardiac CTC data in real time. HealthImaging.com (12/10) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • Activists blast draft of disclosure rules in Mass.
    Health care advocates criticized proposed regulations that would ban Massachusetts doctors from taking drugmakers' free meals and vacations but would not require them to report payments for research or clinical tests. The proposal would allow research payments to remain private in a bid to keep clinical trials in the state, Massachusetts Public Health Commissioner John Auerbach said. Boston Herald (12/11) LinkedInFacebookTwitterEmail this Story
  • European Commission proposes new requirements for HIV tests
    The European Commission has released a draft document recommending new requirements for HIV antibody/antigen combined tests. The changes are meant to reflect improvements in the sensitivity and performance of in vitro diagnostic device technology, the EC said. FDAnews (12/10) LinkedInFacebookTwitterEmail this Story
AdvaMed News 
  • FDA Inspections: What to Expect & What to Do -- Jan. 22, 2009, Orlando, Fla.
      
    Every medical technology company will go through FDA inspections. Knowing what to expect, what FDA expects, common pitfalls, how to prepare employees and handle your response will help minimize the risks and improve the outcome of this unavoidable, sometimes challenging, experience. A leading regulatory attorney, industry experts and FDA investigators teach you the regulatory authority, typical procedures and best practices for managing an inspection. Register now. Medical Technology Learning Institute -- Education Beyond a Degree LinkedInFacebookTwitterEmail this Story
  • Enhancing Safety Risk Management
     
    During this seminar on Jan. 20, 2009, in Orlando, Fla., you'll learn from FDA and industry leaders:

    • Causes of safety related recalls and how they could have been prevented
    • What to include in your risk analyses, risk evaluation, risk control and post-production information
    • Lessons from safety recalls and how they can be prevented
    You'll also get a checklist with more than 130 common safety risk mitigation techniques commonly used to reduce risk. Get more information. Medical Technology Learning Institute -- Education Beyond a Degree LinkedInFacebookTwitterEmail this Story
Learn more about AdvaMed ->About AdvaMed  |  Join  |  Courses  |  Events  |  Newsroom

 
Position TitleCompany NameLocation
Senior Regulatory ManagerBIOTRONIK, Inc.Portland, Oregon
Director of MarketingHeart Rhythm SocietyWashington DC
Manager, Practice Management and ReimbursementHeart Rhythm SocietyWashington DC
Associate Director QA/RAATEX Technologies, Inc.Pinebluff, North Carolina
Sr. Product Marketing ManagerEdwards LifesciencesIrvine, California
Click here to view more job listings.

  SmartQuote 
Our doubts are traitors and make us lose the good we oft might win, by fearing to attempt."
--William Shakespeare,
English playwright


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Ashley McMaster
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information